Skip to main content
Andreas Schlitzer
© Volker Lannert / Uni Bonn

News categories: Honors & Funding

Highly Cited Researchers 2022

ImmunoSensation is prominently represented in the “Highly Cited Researchers 2022” ranking

The Bonn Cluster of Excellence ImmunoSensation2 once more is strongly represented in this year’s ranking of highly cited researchers. Prof. Eicke Latz, head of the Institute of Innate Immunity at the University Hospital Bonn, Prof. Andreas Schlitzer, head of the Quantitative Systems Biology group at LIMES Institute of Bonn University as well as Prof. Joachim Schultze, Director Systems Medicine at the DZNE, are among the year’s most influential researchers once more.

The researchers on the list of "Highly Cited Researchers" are among the world's most influential one percent of their scientific field, according to the creators of the ranking. The benchmark is the frequency with which their scientific publications have been cited by other scientists in the last ten years (period from 2011 to 2021). The ranking is published annually by the Web of Science Group and includes around 6,200 scientists in 21 subject categories.

Prof. Eicke Latz is awarded as one of the most influential researchers in the field of immunology for the nineth time in a row. He has been ranked as one of the “highly cited researchers” every single year, since 2014. Prof. Andreas Schlitzer receives the award for the fourth time. He has been ranked as “highly cited researcher” in cross-Field annually, starting 2019. Prof. Joachim Schultze is ranked for the second time. He had been among the “highly cited researchers” in cross-Field in 2021 and this year belongs to the most influential researchers in the field of immunology.

The full list of researchers is published by web of science and can be found at https://clarivate.com/highly-cited-researchers/

Related news

PrepAIred

News categories: Honors & Funding

Precise active ingredients against pancreatic cancer

Pancreatic cancer remains one of the deadliest forms of cancer. At the German Cancer Congress 2026, German Cancer Aid is now presenting three large-scale projects that it is funding as part of its “German Alliance for Pancreatic Cancer” funding priority. In the funded project PrepAIred, Bonn researchers , in cooperation with the University of North Carolina (USA), want to use AI-based protein design to specifically combat pancreatic cancer. German Cancer Aid is funding the project with a total of 1.99 million euros over a period of four years.
View entry
Gruppenbild Preistrager Lisec Artz Preisverleihung

News categories: Honors & Funding

Niklas Klümper and Varun Venkataramani receive Lisec-Artz Prize

Dr. Varun Venkataramani of the Faculty of Medicine at Heidelberg University and ImmunoSensation² member Dr. Niklas Klümper of the University Hospital Bonn have been awarded the Lisec Artz Prize for their outstanding cancer research. The University of Bonn Foundation and the University of Bonn Faculty of Medicine presented the awards to the two researchers on Tuesday, November 18, 2025 at the University Hospital Bonn (UKB) as part of the Cluster Science Days event held by the ImmunoSensation² Cluster of Excellence. The prize is worth a total of 15,000 euros.
View entry
20251103 PM Prof Wihelm

News categories: Honors & Funding

Prof. Christoph Wilhelm receives €1.25 million DFG funding for Reinhart-Koselleck project

The German Research Foundation (DFG) is funding a Reinhart-Koselleck project at the University Hospital Bonn (UKB) within the Cluster of Excellence ImmunoSensation² at the University of Bonn with €1.25 million. The research team led by Prof. Christoph Wilhelm, Chair of Immunopathology at the Institute of Clinical Chemistry and Clinical Pharmacology, aims to investigate how the body maintains the balance of the gut microbiome during periods of illness and food scarcity.
View entry

Back to the news overview